JPWO2020247603A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020247603A5 JPWO2020247603A5 JP2021572445A JP2021572445A JPWO2020247603A5 JP WO2020247603 A5 JPWO2020247603 A5 JP WO2020247603A5 JP 2021572445 A JP2021572445 A JP 2021572445A JP 2021572445 A JP2021572445 A JP 2021572445A JP WO2020247603 A5 JPWO2020247603 A5 JP WO2020247603A5
- Authority
- JP
- Japan
- Prior art keywords
- solid oral
- dosage form
- oral dosage
- weight
- amisulpride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962856863P | 2019-06-04 | 2019-06-04 | |
US62/856,863 | 2019-06-04 | ||
US202063011584P | 2020-04-17 | 2020-04-17 | |
US63/011,584 | 2020-04-17 | ||
PCT/US2020/036084 WO2020247603A1 (en) | 2019-06-04 | 2020-06-04 | Modified release formulations and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022535894A JP2022535894A (ja) | 2022-08-10 |
JPWO2020247603A5 true JPWO2020247603A5 (es) | 2023-06-13 |
Family
ID=73652146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021572445A Pending JP2022535894A (ja) | 2019-06-04 | 2020-06-04 | 放出調節製剤およびその使用 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20220323409A1 (es) |
EP (1) | EP3980008A4 (es) |
JP (1) | JP2022535894A (es) |
WO (1) | WO2020247603A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019113084A1 (en) | 2017-12-05 | 2019-06-13 | Sunovion Pharmaceuticals Inc. | Crystal forms and production methods thereof |
KR20220018004A (ko) | 2019-06-04 | 2022-02-14 | 선오비온 파마슈티컬스 인코포레이티드 | 조절 방출 제형 및 이의 용도 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010023690A2 (en) * | 2008-08-28 | 2010-03-04 | Torrent Pharmaceuticals Ltd. | Prolonged release formulation of amisulpride |
GB201004020D0 (en) * | 2010-03-11 | 2010-04-21 | Acacia Pharma Ltd | New therapeutic use |
US10441544B2 (en) * | 2017-10-10 | 2019-10-15 | Douglas Pharmaceuticals, Ltd. | Extended release pharmaceutical formulation |
SG11202005016SA (en) * | 2017-12-05 | 2020-06-29 | Sunovion Pharmaceuticals Inc | Nonracemic mixtures and uses thereof |
KR20220018004A (ko) * | 2019-06-04 | 2022-02-14 | 선오비온 파마슈티컬스 인코포레이티드 | 조절 방출 제형 및 이의 용도 |
-
2020
- 2020-06-04 JP JP2021572445A patent/JP2022535894A/ja active Pending
- 2020-06-04 EP EP20819312.8A patent/EP3980008A4/en not_active Withdrawn
- 2020-06-04 US US17/616,460 patent/US20220323409A1/en not_active Abandoned
- 2020-06-04 WO PCT/US2020/036084 patent/WO2020247603A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8796337B2 (en) | Composition and method for treating neurological disease | |
US7374781B2 (en) | Sustained release formulations containing acetaminophen and tramadol | |
TWI241911B (en) | Sustained release ranolazine formulations | |
US20070298098A1 (en) | Controlled Release Compositions Comprising Levetiracetam | |
WO2009034541A9 (en) | Controlled release pharmaceutical dosage forms of trimetazidine | |
WO2021129735A1 (zh) | 一种固体制剂及其制备方法和用途 | |
AU2014299447B2 (en) | Pharmaceutical capsule composite formulation comprising tadalafil and tamsulosin | |
KR101156054B1 (ko) | 안정한 에페리손 함유 서방성 의약조성물 | |
RU2006122517A (ru) | Фармацевтический состав для прямого прессования, предназначенный для перорального введения cci-779 | |
AU2012349771A1 (en) | Methods for treating cardiovascular disorder | |
RU2008137229A (ru) | Ниацинсодержащая фармацевтическая композиция (варианты) и таблеточный препарат (варианты), способ снижения гиперемии и способ приготовления ниацинсодержащей таблетки | |
KR20170008923A (ko) | 세레콕시브 및 트라마돌을 함유하는 약제학적 조성물 | |
WO2023241688A1 (zh) | 一种用于治疗抗凝血的药物组合物及应用 | |
KR20120033557A (ko) | 레보드로프로피진을 포함하는 속효성과 지속성을 동시에 갖는 약제학적 조성물 | |
KR20100008356A (ko) | 칼슘채널길항제를 포함하는 약제학적 제제 | |
WO2006088864A1 (en) | Controlled release compositions comprising levetiracetam | |
AU2011288256A1 (en) | Oral controlled release pharmaceutical compositions of Blonanserin | |
WO2007010501A2 (en) | A pharmaceutical composition comprising a combination of beta blocker and an ace inhibitor | |
JPWO2020247603A5 (es) | ||
JP2016539171A (ja) | アセブロフィリン及び疎水性徐放性基剤を含む徐放性薬学組成物 | |
JPWO2020247627A5 (es) | ||
KR20140118412A (ko) | 활성 성분으로 에페리손을 함유하는 서방성 제제 조성물 | |
JP2016539109A (ja) | イソニアジドの顆粒およびリファペンチンの顆粒を含むコーティング錠の形態の抗結核性の安定な医薬組成物ならびにその製造方法 | |
EP3727365A2 (en) | Modified release formulations of flurbiprofen | |
KR102330953B1 (ko) | 소듐-1-[6-(모르폴린-4-일)피리미딘-4-일]-4-(1h-1,2,3-트리아졸-1-일)-1h-피라졸-5-올레이트를 함유하는 제약 투여 형태 |